Wall Street Zen cut shares of Callan JMB (NASDAQ:CJMB – Free Report) from a hold rating to a sell rating in a report issued on Saturday morning,Wall Street Zen reports.
Separately, Weiss Ratings reissued a “sell (e+)” rating on shares of Callan JMB in a research report on Friday, July 24th. One analyst has rated the stock with a Sell rating, According to MarketBeat, Callan JMB currently has an average rating of “Sell”.
Read Our Latest Stock Report on Callan JMB
Callan JMB Trading Up 7.5%
Callan JMB (NASDAQ:CJMB – Get Free Report) last issued its quarterly earnings results on Friday, August 14th. The company reported ($0.22) earnings per share for the quarter. The company had revenue of $1.38 million for the quarter. Callan JMB had a negative return on equity of 444.84% and a negative net margin of 191.96%.
Institutional Investors Weigh In On Callan JMB
A hedge fund recently bought a new position in Callan JMB stock. Bard Associates Inc. purchased a new stake in Callan JMB Inc. (NASDAQ:CJMB – Free Report) in the second quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor purchased 229,250 shares of the company’s stock, valued at approximately $184,000. Bard Associates Inc. owned approximately 4.05% of Callan JMB as of its most recent SEC filing.
About Callan JMB
Callan JMB is a vertically integrated logistics and fulfillment company which provides thermal management logistics solutions to the life sciences industry through a combination of proprietary packaging, information technology and specialized cold chain logistics knowhow. We provide a system that utilizes advanced predictive technology to revolutionize the supply chain by guaranteeing the safety, effectiveness, and potency of every product handled to ensure product integrity, and to provide immediate response in time-sensitive industries while ensuring environmental responsibility.
Featured Articles
- Five stocks we like better than Callan JMB
- Carnival and CarMax Pop on Strong Earnings, but Challenges Remain
- 3 Income Stocks Under $30 That Yield More Than the 10-Year Treasury Note
- 3 AI Winners, 3 Very Different Paths to Higher Margins
- Plexus Is Booming—But Can the Growth Story Last?
Receive News & Ratings for Callan JMB Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Callan JMB and related companies with MarketBeat.com's FREE daily email newsletter.
